Background：PLC-L （for PLC-deleted in lung carcinoma） is a PLC family memeber, the expression of which is decreased in small cell lung carcinomas. PLC-L is normally expressed in a variety of fetal and adult organs including the lung. PLC-L is thought to be involved in inositol phospholipid-based intracellular signaling cascade and aberrant expression of PLC-L may contributes to the genesis or progression of human lung carcinoma.
仕様
Synonyms：Inactive phospholipase C-like protein 1,Inactive protein 1,Phospholipase C deleted in lung carcinoma,Phospholipase C epsilon,Phospholipase C like 1,Phospholipase C related but catalytically inactive protein,Phospholipase C related,but catalytically inactive protein,Phospholipase C-deleted in lung carcinoma,Phospholipase C-related but catalytically inactive protein,Phospholipase C-related catalytically,PLC-L1,PLCE,PLCL,PLCL1,PLCL1,PLDL1,PRIP
Host：Rabbit
Reactivity：Human
Applications：IHC,ELISA
Concentration：0.6mg/mL
Immunogen：Synthetic peptide of human PLCL1
Purification Method：Affinity purification
Clonality：Polyclonal
Conjugation：Unconjugated
Buffer：PBS with 0.05％ sodium azide, 50％ glycerol, PH7.3
